
Unimed Drugs Pvt Ltd
About Unimed Drugs Pvt Ltd
Data last updated:
Unimed Drugs Pvt Ltd is a private limited company based in Kolkata, West Bengal, India. It operates in the speciality chemicals segment of the chemicals sector. It was incorporated on 28 April 1987 and has been in existence for over 39 years.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U24232WB1987PTC042256.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Sangita Kariwala and Sumit Kariwala.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 16B Shakes Peare Sarani, Kolkata, West Bengal, India – 700071.
As per the financials filed for FY 2017, the company reported a revenue of ₹35,690. For the same year it recorded a net profit of ₹12,992 (net margin 36.4%) and EBITDA of -₹14,061 (EBITDA margin -39.4%).
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Unimed Drugs Pvt Ltd's registered office is in Kolkata, West Bengal. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address16B Shakes Peare Sarani, Kolkata, West Bengal, India – 700071
- IndustryChemicals, Other Chemical Product, Manufacturing
To see the full contact details of Unimed Drugs Pvt Ltd, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Unimed Drugs Pvt Ltd
FY 2024 filings availableUnimed Drugs Pvt Ltd reported revenue of ₹35,690 for FY 2017.
Financial Statement Summary
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | ₹35,690 | ||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | -₹14,061 | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹12,992 | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | -39.4% | ||
| Net Profit Margin | 36.4% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Unimed Drugs Pvt Ltd, buy the company report.
Board of directors of Unimed Drugs Pvt Ltd
Unimed Drugs has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sangita Kariwala Also directs: Dhaamak Natural LLP, Vasanshi Fashions Private Limited | Additional Director | 08 Feb 2022 | 4 Years 9 Months | Current |
| Sumit Kariwala Also directs: Dhaamak Natural LLP | Additional Director | 08 Feb 2022 | 4 Years 9 Months | Current |
Auditor
Unimed Drugs Pvt Ltd is audited by P.MOHATA AND COMPANY for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| P.MOHATA AND COMPANY | FY 2017 | 326689E |
Shareholding
The shareholding of Unimed Drugs Pvt Ltd is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Unimed Drugs Pvt Ltd, buy the company report.
Legal cases
No court or tribunal cases involving Unimed Drugs Pvt Ltd are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Unimed Drugs Pvt Ltd; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Unimed Drugs Pvt Ltd; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Unimed Drugs Pvt Ltd has 5 board changes on record since 2012: 2 appointments and 3 cessations. The latest: Ramavtar Jhunjhunwala ceased to be Director on 09 Feb 2022.
Frequently asked questions
Unimed Drugs is an active private limited company based in Kolkata, West Bengal, India. The company works in other chemical product, within the chemicals industry. It was incorporated on 28 April 1987 (39+ years old) and is registered under CIN U24232WB1987PTC042256.
Unimed Drugs has 2 current directors:
- Sangita Kariwala - Additional Director
- Sumit Kariwala - Additional Director
The latest financial statements of Unimed Drugs on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Unimed Drugs is U24232WB1987PTC042256. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Unimed Drugs was incorporated on 28 April 1987, making it 39+ years old. It is registered with the Registrar of Companies, Kolkata.
Ramavtar Jhunjhunwala ceased to be Director on 09 Feb 2022. Vandana Sanganeria ceased to be Director on 09 Feb 2022. Sangita Kariwala was appointed as Additional Director on 08 Feb 2022. Unimed Drugs has 5 board changes on record in total.
The registered office of Unimed Drugs is at 16B Shakes Peare Sarani, Kolkata, West Bengal, India – 700071.
Unimed Drugs operates in the chemicals industry, in the other chemical product segment.
The compliance status of Unimed Drugs is compliant as of 07 July 2026. The company is actively filing with the Registrar of Companies.
Unimed Drugs can be reached at its registered office: 16B Shakes Peare Sarani, Kolkata, West Bengal, India – 700071.

